Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle(University of Toronto), Elfriede Pahl(Northwestern University), Tohru Kobayashi(Jichi Medical University), Tsutomu Saji, Mary Anne Jackson, Jane W. Newburger(Oregon Health & Science University), Jane C. Burns(Rady Children's Hospital-San Diego), Annette Baker(Boston Children's Hospital), Anne F. Bolger, Anne H. Rowley(Northwestern University), Michael H. Gewitz(New York Medical College), Masato Takahashi(National Hospital Organization Hokkaido Medical Center), Mei‐Hwan Wu(National Taiwan University), Pinak Shah
Cited by 3,695
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
|Circulation|2004|1.9k
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
|Journal of Cardiothoracic and Vascular Anesthesia|1997|1.3k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k